Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1228 ARTÍCULOS , VIENDO DEL 781 AL 795

[Assessing Motor-Cognition Interaction of Patients with Cognitive Disorders: Clinical Aspects]

Schniepp R, Wuehr M, Schöberl F, Zwergal A.

Fortschr Neurol Psychiatr. 2016 Aug;84(8):469-79. doi: 10.1055/s-0042-110651. Epub 2016 Aug 29.

The impact of depressive symptoms on health-related quality of life in patients with subjective cognitive decline, mild cognitive impairment, and Alzheimer's disease

Pusswald G, Moser D, Pflüger M, Gleiss A, Auff E, Stögmann E, Dal-Bianco P, Lehrner J.

Int Psychogeriatr. 2016 Dec;28(12):2045-2054. doi: 10.1017/S1041610216001289. Epub 2016 Aug 31.

Pesticide exposure and risk of Alzheimer's disease: a systematic review and meta-analysis

Yan D, Zhang Y, Liu L, Yan H.

Sci Rep. 2016 Sep 1;6:32222. doi: 10.1038/srep32222.

Traumatic brain injury as a risk factor for Alzheimer's disease: current knowledge and future directions

Dams-O'Connor K, Guetta G, Hahn-Ketter AE, Fedor A.

Neurodegener Dis Manag. 2016 Oct;6(5):417-29. doi: 10.2217/nmt-2016-0017. Epub 2016 Sep 7.

Drug use in persons with and without Alzheimer's disease aged 90 years or more

Taipale H, Koponen M, Tanskanen A, Tolppanen AM, Tiihonen J, Hartikainen S.

Age Ageing. 2016 Nov;45(6):900-904. doi: 10.1093/ageing/afw141. Epub 2016 Sep 8.

Microbleeds in Alzheimer's Disease: A Neuropsychological Overview and Meta-Analysis

Sepehry AA, Rauscher A, Hsiung GY, Lang DJ.

Can J Neurol Sci. 2016 Nov;43(6):753-759. doi: 10.1017/cjn.2016.296. Epub 2016 Sep 19.

Refining Mild-to-Moderate Alzheimer Disease Screening: A Tool for Clinicians

Del Campo N, Cesari M, Canevelli M, Hoogendijk EO, Lilamand M, Kelaiditi E, Soto ME, Ousset PJ, Weiner MW, Andrieu S, Vellas B; ICTUS and REAL.FR/DSA groups.

J Am Med Dir Assoc. 2016 Oct 1;17(10):913-20. doi: 10.1016/j.jamda.2016.06.005.

Sex biology contributions to vulnerability to Alzheimer's disease: A think tank convened by the Women's Alzheimer's Research Initiative

Snyder HM, Asthana S, Bain L, Brinton R, Craft S, Dubal DB, Espeland MA, Gatz M, Mielke MM, Raber J, Rapp PR, Yaffe K, Carrillo MC.

Alzheimers Dement. 2016 Nov;12(11):1186-1196. doi: 10.1016/j.jalz.2016.08.004. Epub 2016 Sep 27.

Spontaneous confabulations in amnestic-mild cognitive impairment due to Alzheimer's disease: a new (yet old) atypical variant?

Abbate C, Trimarchi PD, Rotondo E, Inglese S, Nicolini P, Rossi PD, Arosio B, Mari D.

Neurocase. 2016 Oct;22(5):451-460. doi: 10.1080/13554794.2016.1239743. Epub 2016 Oct 5.

Regulation of Oligodendrocyte Differentiation and Myelination by Nuclear Receptors: Role in Neurodegenerative Disorders

Sandoval-Hernández A, Contreras MJ, Jaramillo J, Arboleda G.

Adv Exp Med Biol. 2016;949:287-310. doi: 10.1007/978-3-319-40764-7_14.

Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3

Herold C, Hooli BV, Mullin K, Liu T, Roehr JT, Mattheisen M, Parrado AR, Bertram L, Lange C, Tanzi RE.

Mol Psychiatry. 2016 Nov;21(11):1608-1612. doi: 10.1038/mp.2015.218. Epub 2016 Feb 2.

Primary Progressive Aphasia in the Network of French Alzheimer Plan Memory Centers

Magnin E, Démonet JF, Wallon D, Dumurgier J, Troussière AC, Jager A, Duron E, Gabelle A, de la Sayette V, Volpe-Gillot L, Tio G, Evain S, Boutoleau-Bretonnière C, Enderle A, Mouton-Liger F, Robert P, Hannequin D, Pasquier F, Hugon J, Paquet C; ePLM collaborators.

J Alzheimers Dis. 2016 Oct 18;54(4):1459-1471. doi: 10.3233/JAD-160536.

Risk factor SORL1: from genetic association to functional validation in Alzheimer's disease

Andersen OM, Rudolph IM, Willnow TE.

Acta Neuropathol. 2016 Nov;132(5):653-665. doi: 10.1007/s00401-016-1615-4. Epub 2016 Sep 16.

TREM2 p.H157Y Variant and the Risk of Alzheimer's Disease: A Meta-Analysis Involving 14,510 Subjects

Jiang T, Hou JK, Gao Q, Yu JT, Zhou JS, Zhao HD, Zhang YD.

Curr Neurovasc Res. 2016;13(4):318-320. doi: 10.2174/1567202613666160808095530.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias